You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
【瑞通認股證牛熊證】油股暴瀉 有資金開好倉博反彈 瑞聲曾考驗50元見支持 海油購25592/ 中化購18767/ 中油購14447/ 瑞聲購13108 牛59434
阿思達克 03-09 11:00
雖然美國上月非農業職位增長勝市場預期,但新型肺炎疫情擴大,市場憂慮引發經濟衰退,美股繼續受挫。道指上周五曾跌近900點,最終收報25864點,跌256點(或0.9%)。另外,沙特阿拉伯擬發動「原油價格戰」,油價暴瀉,避險資金流入債市,美國10年期債息跌穿0.5厘創歷史新低,外圍股市繼續受壓。恆指上周五收報26146點,跌621點(或2.3%),今早暴瀉逾1000點,回至25000點之水平,重返去年八月水平。恆指好倉(牛證及認購權證)上周五淨流入逾1.5億港元(下同),恆指淡倉(熊證及認沽權證)同日淨流出約1.9億元,反映投資者趁跌市部署好倉博反彈。上周五恆指牛證街貨重貨區為收回價25800至25899點,而熊證街貨重貨區為收回價26800至26899點。油價暴瀉,相關股全數裂口急挫。中海油(00883) 於「三桶油」中表現最差,大幅低開近22%,報8.3元,其後跌幅收窄至近15%,於9元水平徘徊。中石油(00857)最多大跌逾13%,低見2.65元,其後跌幅維持近9%;中石化(00386)低開7.4%後,跌幅略縮至近6%,於3.7元附近上落。中國生物製藥(01177)上周連升四日累漲9%後,上周五曾高見12.76元,創逾年半高,不過其後獲利盤出現,輕微倒跌收市,報12.32元。今早曾挫約6%,回至11.6元以下,下試多條平均線支持,其後跌幅收窄至約5%。集團將於今月30日公布末期業績。上周五分別有24萬和32萬元淨流入其好倉和淡倉。瑞聲(02018)上周五收報52.6元,跌近1%,續受制下移中的10天線,今早續挫約半成,險守50元關口,重返去年10月時水平。瑞聲由去年八月底32.85元起開展升浪,升至今年一月初的72.9元高位,現已回調超過50%的升幅,若回調61.8%升幅則會見48.15元水平。上周五分別有13萬和20萬元淨流出其好倉和淡倉。將於今周四公布末期業績的太古A(00019),上周五跌穿70元收市,報69.35元,下跌2.6%,今早繼續隨市向下,跌逾5%至66元以下,失守上月初低見的67.65元支持,創52周低。上周五其輪證資金流不明顯。建行(00939)近期獲北水密吸,不過上周五股價跌幅多於大市,收跌2.7%於6.35元,一舉失守10天、20天、50天和100天線。建行今早低位再跌約4%,回落至6.1元,失250天線(6.27元)。建行上周五錄9.18億元北水淨流入,續為北水淨流入最多股份。輪證資金流方面,上周五有410萬元淨流入其好倉,淡倉同日則有98萬元淨流出。瑞通相關認股證之選擇:海油價外、中年期購25592,行使價:11.5元,2020年10月到期,實際槓桿:5.3倍中化價外、長期購18767,行使價:5.78元,2020年12月到期,實際槓桿:8倍中油價外、中短期購14447,行使價:3.88元,2020年9月到期,實際槓桿:9.1倍中藥輕微價外、短期購13693,行使價:12.98元,2020年5月到期,實際槓桿:5.6倍瑞聲價外、中年期購13108,行使價:61.9元,2020年9月到期,實際槓桿:4.6倍瑞聲貼價、中年期沽22609,行使價:49.98元,2020年9月到期,實際槓桿:3倍太A輕微價外、中年期購14435,行使價:73.88元,2020年9月到期,實際槓桿:8.5倍阿里價外、中短期購22402,行使價:232.8元,2020年8月到期,實際槓桿:7.8倍阿里輕微價外、中短期沽23203,行使價:182.08元,2020年7月到期,實際槓桿:7倍騰訊輕微價外、中短期購18192,行使價:408.9元,2020年6月到期,實際槓桿:9.6倍騰訊貼價、中短期沽22039,行使價:365.85元,2020年6月到期,實際槓桿:7.4倍瑞通相關牛熊證之選擇:恆指牛證52811,收回價:24610點,槓桿比率:40.5倍恆指熊證59552,收回價:26490點,槓桿比率:14.1倍中化牛證57687,收回價:3.58元,槓桿比率:11.6倍中藥牛證65873,收回價:10.4元,槓桿比率:6倍瑞聲牛證59434,收回價:48.8元,槓桿比率:7.7倍瑞聲熊證59495,收回價:56.6元,槓桿比率:4.9倍建行牛證57658,收回價:5.48元,槓桿比率:8.2倍建行熊證57657,收回價:6.6元,槓桿比率:9.3倍 重要風險通知本結構性產品並無抵押品。結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。閣下投資前應了解產品風險,如有需要應諮詢專業建議。~重要聲明: 以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account